Minaris Regenerative Medicine Co., Ltd.

Minaris Regenerative Medicine is a leading global contract development and manufacturing organization (CDMO) dedicated to the production of cell and gene therapy products. For more than 20 years, we have been offering clinical and commercial manufacturing services, development solutions, and technologies while providing outstanding quality and reliability. 

Our Vision: Creating Future Cell Therapy Miracles Together
 

Over 20 Years' Worth of Experience
Our state-of-the-art facilities located within the United States (New Jersey and California), Europe (Germany), and Asia (Japan) allow us to supply patients worldwide with life-changing therapies.

As a pioneer within this industry, we are proud to have built strong relationships with a number of international clients, ranging from big pharma to biotech to academia.

Our client-focused approach is designed to deliver world-class service to your specific needs and unique challenges. Our goal is to be viewed as your partner and an extension of your in-house team by delivering the expertise, strategy, teamwork, efficiency, and accessibility you demand. Doing so allows these life-changing therapeutics to be available to patients worldwide at an accelerated rate.